These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6973553)

  • 1. Radioprotection of normal and malignant tissue in the mouse by diethylaminoreserpine.
    Lehnert S; Fisher G; Methot G
    Int J Radiat Biol Relat Stud Phys Chem Med; 1981 Jul; 40(1):63-73. PubMed ID: 6973553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of diethylaminoreserpine to a transplantable tumor: the significance of the presence of hypoxic cells.
    Lehnert S
    Cancer Res; 1982 Aug; 42(8):3028-32. PubMed ID: 7093951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity to tumour cells of diethylaminoreserpine.
    Lehnert S
    Br J Cancer Suppl; 1980 Apr; 4():222-5. PubMed ID: 6932928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses of bone marrow and tumor cells to acute and protracted irradiation.
    Frindel E; Hahn GM; Robaglia D; Tubiana M
    Cancer Res; 1972 Oct; 32(10):2096-103. PubMed ID: 4638856
    [No Abstract]   [Full Text] [Related]  

  • 5. Repair of potentially lethal damage in vivo in solid tumor cells after x-irradiation.
    Hahn GM; Rockwell S; Kallman RF; Gordon LF; Frindel E
    Cancer Res; 1974 Feb; 34(2):351-4. PubMed ID: 4810908
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy.
    Urano M; Kuroda M; Reynolds R; Oberley TD; St Clair DK
    Cancer Res; 1995 Jun; 55(12):2490-3. PubMed ID: 7780953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of diethylaminoreserpine with cells of a transplantable tumour in vivo.
    Lehnert S
    Br J Cancer; 1984 Dec; 50(6):847-51. PubMed ID: 6498082
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioprotection of bone marrow stem cell subsets by interleukin-1 and kit-ligand: implications for CFU-S as the responsible target cell population.
    van Os R; Lamont C; Witsell A; Mauch PM
    Exp Hematol; 1997 Mar; 25(3):205-10. PubMed ID: 9091295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RSR13, a synthetic allosteric modifier of hemoglobin, as an adjunct to radiotherapy: preliminary studies with EMT6 cells and tumors and normal tissues in mice.
    Rockwell S; Kelley M
    Radiat Oncol Investig; 1998; 6(5):199-208. PubMed ID: 9822166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of spleen colony-forming units (CFU-S) of irradiated bone marrow cells in mice: evidence for the existence of a radioresistant subfraction.
    Inoue T; Hirabayashi Y; Mitsui H; Sasaki H; Cronkite EP; Bullis JE; Bond VP; Yoshida K
    Exp Hematol; 1995 Nov; 23(12):1296-300. PubMed ID: 7589285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time distributions of recurrences of immunogenic and nonimmunogenic tumors following local irradiation.
    Suit HD; Sedlacek R; Fagundes L; Goitein M; Rothman KJ
    Radiat Res; 1978 Feb; 73(2):251-66. PubMed ID: 635109
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioprotection of hematopoietic stem cells by interleukin-1.
    Zucali JR; Moreb J; Gibbons W; Alderman J; Suresh A; Zhang Y; Shelby B
    Exp Hematol; 1994 Feb; 22(2):130-5. PubMed ID: 8299734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
    Murata R; Tsujitani M; Horsman MR
    Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are stem cells exposed to ionizing radiation in vivo as effective as nonirradiated transfused stem cells in restoring hematopoiesis?
    Cronkite EP; Inoue T; Hirabayashi Y; Bullis J
    Exp Hematol; 1993 Jun; 21(6):823-5. PubMed ID: 8500580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein induces radioprotection by hematopoietic stem cell quiescence.
    Davis TA; Mungunsukh O; Zins S; Day RM; Landauer MR
    Int J Radiat Biol; 2008 Sep; 84(9):713-26. PubMed ID: 18821385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery from sublethal damage by acutely hypoxic tumour cells in vivo and in vitro.
    McNally NJ; George KC; de Ronde J
    Br J Radiol; 1979 Aug; 52(620):642-9. PubMed ID: 486894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental evaluation of tumor bed effect for C3H mouse mammary carcinoma and for C3H mouse fibrosarcoma.
    Urano M; Suit HD
    Radiat Res; 1971 Jan; 45(1):41-9. PubMed ID: 5099671
    [No Abstract]   [Full Text] [Related]  

  • 18. Stem cell factor enhances the survival of murine intestinal stem cells after photon irradiation.
    Leigh BR; Khan W; Hancock SL; Knox SJ
    Radiat Res; 1995 Apr; 142(1):12-5. PubMed ID: 7534934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
    Grdina DJ; Sigdestad CP; Jovonovich JA
    Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.
    Laterveer L; Zijlmans JM; Lindley IJ; Hamilton MS; Willemze R; Fibbe WE
    Exp Hematol; 1996 Oct; 24(12):1387-93. PubMed ID: 8913284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.